geriatrics

The new treatment for Alzheimer’s disease is only modestly effective: What else can we do now?

The media have been busy in discussion with the results of a large clinical trial that is a new monoclonal antibody therapy, designed to treat patients with the early stages of Alzheimer’s disease. On November 29th, the data was released from the clinical trial, developed by Eisai and Biogen. The outcomes show that the antibody, […]

Read More